Retatrutide still has no brand name. But Lilly filed 20 new trademarks in a month and 19 are built on reta, from VYNRETA to YEZRETA. Here is the whole list, which domains Lilly quietly bought first, and what happened the last time it did this.
Retatrutide beat Zepbound’s numbers in its own trials, and it did not need its top dose to do it. I take Zepbound, I lost about 170 pounds on it, and I am staying put.
Updated September 16, 2026 with the revised label now posted to DailyMed. The FDA approved Mounjaro today to lower the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who are at high risk for those events. That is a real expansion, and for a lot of people it is
Sam Sulek’s peptide company sold retatrutide in a pre-filled pen “for research use only,” while a site under the same NewBioRx branding walked you through putting it in your body. On Sunday afternoon the pen vanished from the store and the instructions site went dark. The vials are still for sale.
Eli Lilly just sued six sellers of retatrutide. The catch is that the drug isn’t approved anywhere, so there is no legitimate version to buy. Whatever these sites are shipping came from outside the drug supply.
When insurance says no, the drug costs what LillyDirect and NovoCare charge, just about wherever you buy it. The prescribing service is the part you can shop, and it runs from about $100 to nearly $1,700 a year.
Oral semaglutide missed its primary endpoint for drinking. The VA’s new 622-person phase 3 is built on the one result that trial failed to get.
The fight that decides what you will pay for the strongest obesity drug yet seen in large trials comes down to a single amino acid, and nobody has won it yet.
I take a diabetes drug and have never had diabetes. A plain-English map of the type 2 diabetes drugs, and why the best ones now protect your heart and kidneys, not just blood sugar.
A BMJ analysis of 262 trials crowned tirzepatide the weight-loss king. But the drug with the hard survival and heart-attack data is the one that finished fifth.
